14,15-dihetre

14,15-dihetre is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 204 references associated with 14,15-dihetre in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 14,15-dihetre

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 14,15-dihetre

MeSH term MeSH ID Detail
Hypertension, Pulmonary D006976 32 associated lipids
Hypertension D006973 115 associated lipids
Insulin Resistance D007333 99 associated lipids
Hypertrophy, Right Ventricular D017380 4 associated lipids
Total 4

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with 14,15-dihetre

Download all related citations
Per page 10 20 50 | Total 46
Authors Title Published Journal PubMed Link
Zhao G et al. Epoxyeicosatrienoic acids protect rat hearts against tumor necrosis factor-α-induced injury. 2012 J. Lipid Res. pmid:22223859
Zhu P et al. Development of a semi-automated LC/MS/MS method for the simultaneous quantitation of 14,15-epoxyeicosatrienoic acid, 14,15-dihydroxyeicosatrienoic acid, leukotoxin and leukotoxin diol in human plasma as biomarkers of soluble epoxide hydrolase activity in vivo. 2011 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:21798825
Park SW et al. The shunting of arachidonic acid metabolism to 5-lipoxygenase and cytochrome p450 epoxygenase antagonizes the anti-cancer effect of cyclooxygenase-2 inhibition in head and neck cancer cells. 2012 Cell Oncol (Dordr) pmid:21656078
Schebb NH et al. Development of an online SPE-LC-MS-based assay using endogenous substrate for investigation of soluble epoxide hydrolase (sEH) inhibitors. 2011 Anal Bioanal Chem pmid:21479549
Kopf PG et al. Angiotensin II regulates adrenal vascular tone through zona glomerulosa cell-derived EETs and DHETs. 2011 Hypertension pmid:21199991
Xiao B et al. Overexpression of cytochrome P450 epoxygenases prevents development of hypertension in spontaneously hypertensive rats by enhancing atrial natriuretic peptide. 2010 J. Pharmacol. Exp. Ther. pmid:20501636
Zheng C et al. Gene delivery of cytochrome p450 epoxygenase ameliorates monocrotaline-induced pulmonary artery hypertension in rats. 2010 Am. J. Respir. Cell Mol. Biol. pmid:20118222
Xu X et al. Increased CYP2J3 expression reduces insulin resistance in fructose-treated rats and db/db mice. 2010 Diabetes pmid:20068141
Liu JY et al. Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model. 2010 Biochem. Pharmacol. pmid:19896470
Shen HC et al. Discovery of 3,3-disubstituted piperidine-derived trisubstituted ureas as highly potent soluble epoxide hydrolase inhibitors. 2009 Bioorg. Med. Chem. Lett. pmid:19682899